V015-5301 Screening compound: 2-{2-[(3-chlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

V015-5301 Screening compound: 2-{2-[(3-chlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide
V015-5301 Screening compound: 2-{2-[(3-chlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-5301
2-{2-[(3-chlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-5301

Molecular Formula

C25H31ClN4O2 (C25 H31 ClN4 O2)

Compound Name

2-{2-[(3-chlorophenyl)methyl]-1H-1,3-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

IUPAC name

2-{2-[(3-chlorophenyl)methyl]-1H-13-benzodiazol-1-yl}-N-[2-(morpholin-4-yl)ethyl]pentanamide

SMILES

CCCC(C(NCCN1CCOCC1)=O)n1c(cccc2)c2nc1Cc1cccc(Cl)c1

InChI

InChI=1S/C25H31ClN4O2/c1-2-6-23(25(31)27-11-12-29-13-15-32-16-14-29)30-22-10-4-3-9-21(22)28-24(30)18-19-7-5-8-20(26)17-19/h3-5,7-10,17,23H,2,6,11-16,18H2,1H3,(H,27,31)/t23-/m0/s1

InChI Key

SYSYBNOEOSPFOU-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD19784352

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

455

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.315

Distribution Coefficient, logD

4.258

Water Solubility, LogSw

-4.23

Polar Surface Area

47.569

Acid Dissociation Constant (pKa)

13.05

Base Dissociation Constant (pKb)

6.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

44.00

V015-5301 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with V015-5301 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-5301?
Check Price and Availability of V015-5301, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-5301 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-5301
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-5301
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-5301 available by request